Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Allergan's handling of Q3 'black eye' dings confidence in management: Analyst
Allergan’s third-quarter numbers weren’t good.
FDA savages Chinese API maker in warning letter
The FDA has savaged a Chinese API maker in a warning letter for a long list of violations, including hiding questionable products, lying to inspectors about products made at the Beijing plant and syst...
Lundbeck raises its 2016 financial guidance based on improved sales and profitability
Revenue reached DKK 11,469 million in the first nine months of 2016 representing an increase of 6% compared to the same period last year Revenue in the US increased 33%...
Brexit threatens supply of new drugs, report warns
British patients could end up not being able to access modern medicines if there is a "hard Brexit", a think tank report endorsed by a former Conservative health minister warned on Wednesday...
Teva asks FDA to raise the bar on new Copaxone copies
Teva may be at a court’s mercy when it comes to IP protection for its long-lasting multiple sclerosis therapy, Copaxone.
ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation
SAN DIEGO, CA, USA I October 31, 2016 I ACADIA Pharmaceuticals Inc.
ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib
CAMBRIDGE, MA, USA I October 31, 2016 I ARIAD Pharmaceuticals, Inc.
UK Study Shows rifaximin-α (XIFAXAN® 550mg / TARGAXAN® 550mg) for Hepatic Encephalopathy May Reduce Costs to Healthcare Systems
Norgine B.
Astellas buys Ganymed to boost immuno-oncology pipeline
Astellas has agreed to pay €422m upfront to buy Ganymed Pharmaceuticals, a German biopharma company specialising in antibody-based cancer drugs.
Are hormonal contraceptives on the way for men?
Most birth control is designed to be used by women, with the exception of condoms and vasectomies.
Depression drugs sales in the US will reach $4.6 billion by 2025, says GlobalData
The US market for major depressive disorders (MDD) will rise from $2.
Seasonal influenza vaccines market will hit $4.3 billion by 2025, says GlobalData
The seasonal influenza vaccine market across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will rise from $3.
594
595
596
597
598
599
600
601
602
